发明名称 |
Triazolo(4,5-D)pyrimidine compounds |
摘要 |
Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows:;
wherein R, X and R1 through R3 are as defined in the specification. |
申请公布号 |
USRE46276(E1) |
申请公布日期 |
2017.01.17 |
申请号 |
US201514976977 |
申请日期 |
2015.12.21 |
申请人 |
AstraZeneca UK Limited |
发明人 |
Hardem David;Ingall Anthony;Springthorpe Brian;Willis Paul;Guile Simon |
分类号 |
C07D239/00;A61K31/519;A61P9/00;A61P9/10;C07D239/48;C07D487/04;C07D487/00;C07C211/40 |
主分类号 |
C07D239/00 |
代理机构 |
|
代理人 |
|
主权项 |
1. A compound of formula (I)wherein:
R1 is C3-5 alkyl optionally substituted by one or more halogen atoms; R2 is a phenyl group, optionally substituted by one or more fluorine atoms; R3 and R4 are both hydroxy; R is XOH, where X is CH2, OCH2CH2 or a bond;or a pharmaceutically acceptable salt or solvate thereof, or a solvate of such a salt provided that:
when X is CH2 or a bond, R1 is not propyl; when X is CH2 and R1 is CH2CH2CF3, butyl or pentyl, the phenyl group at R2 must be substituted by fluorine; when X is OCH2CH2 and R1 is propyl, the phenyl group at R2 must be substituted by fluorine. |
地址 |
London GB |